Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sox0407's Profile
Displaying 601-650 of 2184 result(s).
IPIX Innovation Pharmaceuticals Inc
02/18/2018 3:29:38 PM
B-OM Due Diligence Lastest Update 1 (3)
IPIX Innovation Pharmaceuticals Inc
02/17/2018 5:31:57 PM
BP's interests in the Big Three “ (3)
IPIX Innovation Pharmaceuticals Inc
02/17/2018 5:27:36 PM
SEC Failure-to-deliver Data 2018013 (2)
IPIX Innovation Pharmaceuticals Inc
02/17/2018 5:02:06 PM
FINRA Short Interest of IPIX Settle (1)
IPIX Innovation Pharmaceuticals Inc
02/16/2018 10:44:50 PM
New investors, the statement "48% o (3)
IPIX Innovation Pharmaceuticals Inc
02/15/2018 7:48:16 PM
New investors, the statement "36% o (3)
IPIX Innovation Pharmaceuticals Inc
02/15/2018 1:37:36 AM
Tetraphase’s antibiotic eravacycl
IPIX Innovation Pharmaceuticals Inc
02/14/2018 11:43:51 PM
I don’t think Leo is playing hard (2)
IPIX Innovation Pharmaceuticals Inc
02/14/2018 8:27:13 PM
New investors, the statement "40% o (4)
IPIX Innovation Pharmaceuticals Inc
02/13/2018 8:44:40 PM
New investors, the statement "41% o (4)
IPIX Innovation Pharmaceuticals Inc
02/13/2018 12:41:00 AM
Excellent post by DaubersUP. Dauber (7)
IPIX Innovation Pharmaceuticals Inc
02/12/2018 6:27:16 PM
New investors, the statement "32% o (4)
IPIX Innovation Pharmaceuticals Inc
02/11/2018 11:52:56 PM
Recent IBD Deals 1. Janssen, Therav (5)
IPIX Innovation Pharmaceuticals Inc
02/10/2018 9:57:01 PM
Another $1B partnership by J&J for (2)
IPIX Innovation Pharmaceuticals Inc
02/10/2018 3:39:52 PM
Excellent post by Farrell. farrell9 (5)
IPIX Innovation Pharmaceuticals Inc
02/10/2018 2:50:13 PM
IPIX Milestones, Clinical Trials, R (3)
IPIX Innovation Pharmaceuticals Inc
02/10/2018 12:49:50 PM
Here's where the constant selling p (4)
IPIX Innovation Pharmaceuticals Inc
02/10/2018 12:46:27 PM
New investors, the statement "36% o (3)
IPIX Innovation Pharmaceuticals Inc
02/09/2018 4:49:01 PM
Thanks for reposting! Too bad only (1)
IPIX Innovation Pharmaceuticals Inc
02/08/2018 11:10:23 PM
New investors, the statement "33% o (4)
IPIX Innovation Pharmaceuticals Inc
02/08/2018 4:17:28 PM
Here's another reply to A17. sox040 (3)
IPIX Innovation Pharmaceuticals Inc
02/08/2018 3:45:29 PM
Agreed 100%. Here's my reply to SS (5)
IPIX Innovation Pharmaceuticals Inc
02/07/2018 7:29:33 PM
New investors, the statement "38% o (4)
IPIX Innovation Pharmaceuticals Inc
02/07/2018 6:28:42 PM
More from the 10-Q. Business Develo (1)
IPIX Innovation Pharmaceuticals Inc
02/07/2018 6:06:37 PM
10-Q is out. Kevetrin "The Company (2)
IPIX Innovation Pharmaceuticals Inc
02/07/2018 3:05:45 AM
SEC Charges optionsXpress and Five (4)
IPIX Innovation Pharmaceuticals Inc
02/07/2018 2:57:25 AM
New investors, the statement "18% o (3)
IPIX Innovation Pharmaceuticals Inc
02/05/2018 11:20:08 PM
New investors, the statement "12% o (3)
IPIX Innovation Pharmaceuticals Inc
02/05/2018 7:26:36 PM
FINRA Short Interest of IPIX Settle (2)
IPIX Innovation Pharmaceuticals Inc
02/04/2018 3:27:25 PM
B-OM Due Diligence Lastest Update 1 (7)
IPIX Innovation Pharmaceuticals Inc
02/03/2018 9:24:41 PM
New investors, naked shorting is al (2)
IPIX Innovation Pharmaceuticals Inc
02/03/2018 3:11:52 AM
New investors, the statement "29% o (3)
IPIX Innovation Pharmaceuticals Inc
02/02/2018 1:59:35 PM
Reasons why IPIX is very busy. 1. ~ (5)
IPIX Innovation Pharmaceuticals Inc
02/01/2018 11:15:55 PM
Actually the magic number is 73%. â (1)
IPIX Innovation Pharmaceuticals Inc
02/01/2018 6:16:01 PM
The K-OC trial is no longer listed (5)
IPIX Innovation Pharmaceuticals Inc
02/01/2018 6:11:37 PM
New investors, the statement "38% o (4)
IPIX Innovation Pharmaceuticals Inc
02/01/2018 2:46:26 PM
Here’s a case against Goldman Sac (1)
IPIX Innovation Pharmaceuticals Inc
02/01/2018 2:24:28 PM
This case refutes Alan’s claim th (1)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 8:31:38 PM
SEC charges broker-dealer and three (3)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 8:19:03 PM
New investors, the statement "49% o (5)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 8:08:27 PM
But it's okay for Alan to call me a (3)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 6:04:45 PM
Just for the record, I didn't ask A (1)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 3:37:17 PM
To Drano and my fellow longs, my in (6)
IPIX Innovation Pharmaceuticals Inc
01/31/2018 1:53:24 AM
I agree that they don’t reflect n (2)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 9:47:24 PM
This argument doesn't just happen h (2)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 9:37:26 PM
If the SP went up after someone sho (2)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 8:26:44 PM
Here's why I interpreted the statem (2)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 8:17:37 PM
Thanks LE! I do feel being bullied (2)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 8:12:17 PM
I respectfully disagree. Here's a d (1)
IPIX Innovation Pharmaceuticals Inc
01/30/2018 7:56:43 PM
It could also mean short positions (2)
Go to page:
  • << First
  • < Previous
  • 12
  • 13
  • Next >

Recent Articles

  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • A Decade of Growth: $100 in Live Nation Entertainment's Journey
  • Crypto Market Surges—Will the Bull Momentum Continue?
  • Hims & Hers: A Bright Future Amidst Market Challenges
  • OZAK AI Raises $1.5M in Presale, Captivating AI Investors
  • Investigation into Corporate Governance of Key Companies
  • How A Small Investment In McKesson Grew Over 5 Years
  • PSEG Urges Shareholders to Avoid Mini-Tender Offers by TRC Capital
  • Investing in Canadian Natural Resources: A 5-Year Journey
  • Exploring Energy Transfer's Impressive Five-Year Growth
  • TTEC's Leadership Reassures Stakeholders Amid Changes
  • Grupo Cox's Landmark Acquisition Reshapes Energy Landscape
  • Navigating Market Trends: Insights into Seasonal Volatility
  • Navigating the Securities Class Action for Investors of RCKT
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site